Lanean...
Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
Immune checkpoint inhibitors have quickly become a critical component to the management of advanced renal cell carcinoma. These therapies have been approved for patients who are treatment-naïve and who have progressed on anti-angiogenesis agents. Combinations of immune checkpoint inhibitors with ant...
Gorde:
| Argitaratua izan da: | Semin Nephrol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7164329/ https://ncbi.nlm.nih.gov/pubmed/32130969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semnephrol.2019.12.009 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|